Latest news
AstraZeneca Drug Extends Survival in Advanced Gastric Cancer - MyChesCoMyChesCo · Sat, 08 Aug 2026 10:20:00 GMTSonesitatug Vedotin Extends Survival in Advanced Gastric Cancer - Cure TodayCure Today · Wed, 29 Jul 2026 19:41:06 GMTCathy Eng: We Need to Reduce Access Barriers to Colorectal Cancer Treatment for Texas Latinos - OncodailyOncodaily · Tue, 28 Jul 2026 13:32:50 GMTHong Kong-listed Keymed Biosciences’ gastric cancer drug meets late-stage trial goals - 1470 & 100.3 WMBD1470 & 100.3 WMBD · Tue, 28 Jul 2026 07:00:00 GMTAstraZeneca's Claudin 18.2-targeting ADC passes pivotal gastric cancer test - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 20:25:00 GMTSonesitatug Vedotin Improves Survival in CLDN18.2-Positive Gastric Cancer - Targeted OncologyTargeted Oncology · Mon, 27 Jul 2026 16:08:21 GMTSonesitatug Vedotin Improves Overall Survival in CLDN18.2+ Gastric Cancer - CancerNetworkCancerNetwork · Mon, 27 Jul 2026 16:02:55 GMTSonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers - AstraZenecaAstraZeneca · Mon, 27 Jul 2026 07:00:00 GMT